Neuropathic pain during treatment for childhood acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 57, Issue 7, 2011, Pages 1147-1153

  Anghelescu, Doralina L ^a   Faughnan, Lane G ^a   Jeha, Sima ^a   Relling, Mary V ^a   Hinds, Pamela S ^b,c   Sandlund, John T ^a   Cheng, Cheng ^a   Pei, Deqing ^a   Hankins, Gisele ^a   Pauley, Jennifer L ^a   Pui, Ching Hon ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Acute lymphoblastic leukemia; Gabapentin; Neuropathic pain; Vincristine

Indexed keywords

GABAPENTIN; OPIATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; DRUG DOSE ESCALATION; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROPATHIC PAIN; NEUROTOXICITY; PAIN ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; AMINES; ANALGESICS; ANALGESICS, OPIOID; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HISTORY, ANCIENT; HUMANS; INCIDENCE; MALE; NEURALGIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; RISK FACTORS; VINCRISTINE;

EID: 80053916125     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23039     Document Type: Article

References (31)

1. Kishi S, Cheng C, French D, et al. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood 2007; 109: 4151-4157.
2. Pui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St. Jude Children's Research Hospital. Blood 2004; 104: 2690-2696.
3. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360: 2730-2741.
4. Bradley WG, Lassman LP, Pearce GW, et al. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci 1970; 10: 107-131.
5. Moore A, Pinkerton R, Vincristine: Can its therapeutic index be enhanced? Pediatr Blood Cancer 2009; 53: 1180-1187.
6. Common Terminology Criteria v2.0 National Cancer Institute 1999.
7. Merkel SI, Voepel-Lewis T, Shayevitz JR, et al. The FLACC: A behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 1997; 23: 293-297.
8. Hockenberry MJ, Wilson D. Wong's essentials of pediatric nursing. St. Louis: Mosby; 2009.
9. von Baeyer CL. Children's self-reports of pain intensity: Scale selection, limitations and interpretation. Pain Res Manag 2006; 11: 157-162.
10. Anghelescu DL, De Armendi AJ, Thompson JW, et al. Vincristine-induced vocal cord paralysis in an infant. Paediatr Anaesth 2002; 12: 168-170.
11. Woods WG, O'Leary M, Nesbit ME. Life-threatening neuropathy and hepatotoxicity in infants during induction therapy for acute lymphoblastic leukemia. J Pediatr 1981; 98: 642-645.
12. Schiavetti A, Frascarelli M, Uccini S, et al. Vincristine neuropathy: Neurophysiological and genetic studies in a case of Wilms tumor. Pediatr Blood Cancer 2004; 43: 606-609.
13. Citak EC, Oguz A, Karadeniz C, et al. Vincristine-induced peripheral neuropathy and urinary bladder paralysis in a child with rhabdomyosarcoma. J Pediatr Hematol Oncol 2008; 30: 61-62.
14. Gomber S, Dewan P, Chhonker D. Vincristine induced neurotoxicity in cancer patients. Indian J Pediatr 2009; 77: 97-100.
15. Chauvenet AR, Shashi V, Selsky C, et al. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Pediatr Hematol Oncol 2003; 25: 316-320.
16. Renbarger JL, McCammack KC, Rouse CE, et al. Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. Pediatr Blood Cancer 2008; 50: 769-771.
17. Kuehl LK, Michaux GP, Richter S, et al. Increased basal mechanical pain sensitivity but decreased perceptual wind-up in a human model of relative hypocortisolism. Pain 2010; 149: 539-546.
18. Egbelakin A, Ferguson M, Macgill EA, et al., Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2011; 56: 361-367.
19. Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain 2007; 127: 199-203.
20. Bennett MI, Smith BH, Torrance N, et al. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 2006; 122: 289-294.
21. Ramchandren S, Leonard M, Mody RJ, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst 2009; 14: 184-189.
22. Keskinbora K, Pekel AF, Aydinli I. The use of gabapentin in a 12-year-old boy with cancer pain. Acta Anaesthesiol Scand 2004; 48: 663-664.
23. McGraw T, Stacey BR. Gabapentin for treatment of neuropathic pain in a 12-year-old girl. Clin J Pain 1998; 14: 354-356.
24. Wheeler DS, Vaux KK, Tam DA. Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy. Pediatr Neurol 2000; 22: 220-221.
25. Butkovic D, Toljan S, Mihovilovic-Novak B. Experience with gabapentin for neuropathic pain in adolescents: Report of five cases. Paediatr Anaesth 2006; 16: 325-329.
26. Lauder GR, White MC. Neuropathic pain following multilevel surgery in children with cerebral palsy: A case series and review. Paediatr Anaesth 2005; 15: 412-420.
27. Harel L, Mukamel M, Brik R, et al. Peripheral neuropathy in pediatric systemic lupus erythematosus. Pediatr Neurol 2002; 27: 53-56.
28. Low AK, Ward K, Wines AP. Pediatric complex regional pain syndrome. J Pediatr Orthop 2007; 27: 567-572.
29. Rusy LM, Troshynski TJ, Weisman SJ. Gabapentin in phantom limb pain management in children and young adults: Report of seven cases. J Pain Symptom Manage 2001; 21: 78-82.
30. Roberts R, Rodriguez W, Murphy D, et al. Pediatric drug labeling: Improving the safety and efficacy of pediatric therapies. JAMA 2003; 290: 905-911.
31. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324-1334.